Linked Data API

Filter

These are the filters currently being used to limit the search results. Click on the remove filter icon to remove the filter.

answer › question first answered	2024-03-18T15:32:05.91Z
min date	2019-05-20
tabling member constituency	Romford
answer › is ministerial correction	false

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are shown at the top of the list. Click on remove this sort to remove a sort and or to reverse the current sort order. Click on the remove all sorting icon to remove all the sorting. Note that sorting can significantly slow down the loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined views, but starred properties are always present no matter what the view. You can star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

Items per page

Choose how many items to view on each page. The more items you view, the longer the page will take to load.

Show Search Form

Search Results

registered interest

date

exactly:

or between:
and

answering body

answering dept id

answering dept short name

answering dept sort name

hansard heading

house id

legislature


pref label

question text

tabling member constituency

tabling member printed

uin

answer

is ministerial correction

date of answer

exactly:

or between:
and

answer text

answering member constituency

answering member printed

question first answered

answering member


label

tabling member


label

1695647

registered interest

date

13/03/2024

answering body

Department of Health and Social Care

answering dept id

answering dept short name

Health and Social Care

answering dept sort name

Health and Social Care

hansard heading

Trastuzumab Deruxtecan

house id

legislature

25259

	pref label	House of Commons

question text

To ask the Secretary of State for Health and Social Care, if her Department will take steps to encourage the England-wide roll-out of the drug Enhertu to aid the treatment of people with breast cancer.

tabling member constituency

Romford

tabling member printed

Andrew Rosindell

uin

18402

answer

is ministerial correction

date of answer

18/03/2024

answer text

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance on whether new licensed medicines should be routinely funded by the National Health Service, based on an assessment of their costs and benefits.The NICE published guidance in 2021 and 2023 recommending Enhertu (trastuzumab deruxtecan) for the treatment of NHS patients with HER2-positive breast cancer through the Cancer Drugs Fund, and it is now available to eligible NHS patients in line with the NICE’s recommendations.The NICE is currently evaluating Enhertu for the treatment of metastatic HER2-low breast cancer, and published final draft guidance on 5 March 2024 that does not recommend it as a clinically and cost-effective use of NHS resources. Stakeholders have until 19 March 2024 to lodge an appeal against the NICE’s recommendations. The NICE currently expects to publish final guidance on 3 April 2024.

answering member constituency

Pendle

answering member printed

Andrew Stephenson

question first answered

18/03/2024 15:32:05

answering member

4044

	label	Biography information for Andrew Stephenson

tabling member

1447

	label	Biography information for Andrew Rosindell